Maria Martha Corvi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maria Martha Corvi has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Andres Mariano Alonso
Laboratorio de Parasitología Molecular, INTECH, CONICET-UNSAM, Av. Intendente Marino Km. 8.2, C.C 164, (B7130IIWA), Chascomús, Prov. Buenos Aires, Argentina
7 shared publications - Sergio Oscar Angel
Laboratorio de Parasitología Molecular, INTECH, CONICET/UNSAM, Chascomús, Argentina
6 shared publications - Luc Gérard Berthiaume
Department of Cell Biology, University of Alberta, Edmonton, Alberta T6G 2H7, Canada
4 shared publications Agustina Ganuza
Laboratorio de Bioquímica y Biología Celular de Parásitos, Instituto Tecnológico de Chascomús (CONICET), Escuela de Bio y Nanotecnología (UNSAM), Chascomus, Argentina
2 shared publications- Agustina Ganuza
Laboratorio de Parasitología Molecular, Instituto Tecnológico de Chascomús (INTECH), Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET)/Universidad Nacional General San Martin (UNSAM), Chascomús, Prov Buenos Aires, Argentina; Escuela de Bio y Nanotecnologías, CONICET/UNSAM, Chascomús, Prov Buenos Aires, Argentina; Laboratorio de Bioquímica y Biología Celular de Parásitos, INTECH, CONICET/UNSAM, Chascomús, Prov Buenos Aires, Argentina
2 shared publications M.G. De Napoli
Universidad Nacional de San Martín, Consejo Nacional de Investigaciones Científicas y Técnicas, Provincia de Buenos Aires, Argentina
2 shared publications
Latest Publications
- 7 August 2025
- Published by Elsevier in DNA Repair
- Vol. 152, 103882
Toxoplasma gondii RAD51 recombinase is required to overcome DNA replication stress and its inactivation leads to bradyzoite differentiation
- 7 August 2025
- Published by Elsevier in DNA Repair
- Vol. 152, 103882
Toxoplasma gondii RAD51 recombinase is required to overcome DNA replication stress and its inactivation leads to bradyzoite differentiation
- 23 December 2023
- Published by Springer Nature in Parasitology Research
- Vol. 123 (1) , 1-7
Triclabendazole and clofazimine reduce replication and spermine uptake in vitro in Toxoplasma gondii
Toxoplasmosis is a worldwide zoonosis caused by the protozoan parasite Toxoplasma gondii. Although this infection is generally asymptomatic in immunocompetent individuals, it can cause serious clinical manifestations in newborns with congenital infection or in immunocompromised patients. As current treatments are not always well tolerated, there is an urgent need to find new drugs against human toxoplasmosis. Drug repurposing has gained considerable momentum in the last decade and is a particularly attractive approach for the search of therapeutic alternatives to treat rare and neglected diseases. Thus, in this study, we investigated the antiproliferative effect of several repurposed drugs. Of these, clofazimine and triclabendazole displayed a higher selectivity against T. gondii, affecting its replication. Furthermore, both compounds inhibited spermine incorporation into the parasite, which is necessary for the formation of other polyamines. The data reported here indicate that clofazimine and triclabendazole could be used for the treatment of human toxoplasmosis and confirms that drug repurposing is an excellent strategy to find new therapeutic targets of intervention.
- 23 December 2023
- Published by Springer Nature in Parasitology Research
- Vol. 123 (1) , 1-7
Triclabendazole and clofazimine reduce replication and spermine uptake in vitro in Toxoplasma gondii
Toxoplasmosis is a worldwide zoonosis caused by the protozoan parasite Toxoplasma gondii. Although this infection is generally asymptomatic in immunocompetent individuals, it can cause serious clinical manifestations in newborns with congenital infection or in immunocompromised patients. As current treatments are not always well tolerated, there is an urgent need to find new drugs against human toxoplasmosis. Drug repurposing has gained considerable momentum in the last decade and is a particularly attractive approach for the search of therapeutic alternatives to treat rare and neglected diseases. Thus, in this study, we investigated the antiproliferative effect of several repurposed drugs. Of these, clofazimine and triclabendazole displayed a higher selectivity against T. gondii, affecting its replication. Furthermore, both compounds inhibited spermine incorporation into the parasite, which is necessary for the formation of other polyamines. The data reported here indicate that clofazimine and triclabendazole could be used for the treatment of human toxoplasmosis and confirms that drug repurposing is an excellent strategy to find new therapeutic targets of intervention.
- Open Access
- 7 January 2021
- Published by Springer Nature in BMC Research Notes
- Vol. 14 (1) , 1-8
Resveratrol induces H3 and H4K16 deacetylation and H2A.X phosphorylation in Toxoplasma gondii
Objective: Resveratrol (RSV) is a multitarget drug that has demonstrated activity against Toxoplasma gondii in macrophage and human foreskin fibroblast (HFF) cell line infection models. However, the mechanism of action of RSV has not yet been determined. Thus, with the aim of identifying a possible mechanism of the anti-T. gondii activity of this compound, we analyzed the effects of RSV on histones H3 and H4 lysine 16 acetylation (H4K16). We also analyzed RSV-induced DNA damage to intracellular tachyzoites by using the DNA damage marker phosphorylated histone H2A.X (γH2AX). Results: RSV inhibited intracellular T. gondii tachyzoite growth at concentrations below the toxic threshold for host cells. The IC50 value after 24 h of treatment was 53 μM. RSV induced a reduction in H4K16 acetylation (H4K16ac), a marker associated with transcription, DNA replication and homologous recombination repair. A similar deacetylation effect was observed on histone H3. RSV also increased T. gondii H2A.X phosphorylation at the SQE motif (termed γH2A.X), which is a DNA damage-associated posttranslational modification. Our findings suggest a possible link between RSV and DNA damage or repair processes that is possibly associated with DNA replication stress.
- 7 January 2021
- Published by Springer Nature in BMC Research Notes
- Vol. 14 (1) , 1-8
Open AccessResveratrol induces H3 and H4K16 deacetylation and H2A.X phosphorylation in Toxoplasma gondii
Objective: Resveratrol (RSV) is a multitarget drug that has demonstrated activity against Toxoplasma gondii in macrophage and human foreskin fibroblast (HFF) cell line infection models. However, the mechanism of action of RSV has not yet been determined. Thus, with the aim of identifying a possible mechanism of the anti-T. gondii activity of this compound, we analyzed the effects of RSV on histones H3 and H4 lysine 16 acetylation (H4K16). We also analyzed RSV-induced DNA damage to intracellular tachyzoites by using the DNA damage marker phosphorylated histone H2A.X (γH2AX). Results: RSV inhibited intracellular T. gondii tachyzoite growth at concentrations below the toxic threshold for host cells. The IC50 value after 24 h of treatment was 53 μM. RSV induced a reduction in H4K16 acetylation (H4K16ac), a marker associated with transcription, DNA replication and homologous recombination repair. A similar deacetylation effect was observed on histone H3. RSV also increased T. gondii H2A.X phosphorylation at the SQE motif (termed γH2A.X), which is a DNA damage-associated posttranslational modification. Our findings suggest a possible link between RSV and DNA damage or repair processes that is possibly associated with DNA replication stress.
- Open Access
Resveratrol induces H2A.X phosphorylation and H4K16 de-acetylation in Toxoplasma gondii
Resveratrol (RSV) is a multi-target drug that demonstrated activity against Toxoplasma gondii in macrophage and HFF cell line infection models. In addition to modulate redox homeostasis, RSV is also an activator of Sir2, a type III HDAC. RSV inhibited intracellular T. gondii tachyzoite growth at concentrations below the toxic effect on host cells. The IC 50 value in a 24-hours treatment was 53 μM. After 96 hours of treatment the maximum non-toxic concentration for host cell, 20 μM, only inhibited T. gondii growth a 50%. RSV induced a reduction in H4K16 acetylation (H4K16ac), a mark associated to transcription, DNA replication and homologous recombination repair, without any effect on H3 acetylation (H3ac). RSV also enhanced the SQE motif phosphorylation on T. gondii H2A.X (termed γH2A.X), a DNA damage associated PTM. Sirtinol, a specific Sir2 inhibitor also inhibited T. gondii but did not altered the acetylation status of H3 and H4K16 as well as H2A.X phosphorylation. Our findings suggest a possible link between RSV and DNA damage or DNA repair process maybe due to DNA replication stress and/or another undetermined mechanism.
Open AccessResveratrol induces H2A.X phosphorylation and H4K16 de-acetylation in Toxoplasma gondii
Resveratrol (RSV) is a multi-target drug that demonstrated activity against Toxoplasma gondii in macrophage and HFF cell line infection models. In addition to modulate redox homeostasis, RSV is also an activator of Sir2, a type III HDAC. RSV inhibited intracellular T. gondii tachyzoite growth at concentrations below the toxic effect on host cells. The IC 50 value in a 24-hours treatment was 53 μM. After 96 hours of treatment the maximum non-toxic concentration for host cell, 20 μM, only inhibited T. gondii growth a 50%. RSV induced a reduction in H4K16 acetylation (H4K16ac), a mark associated to transcription, DNA replication and homologous recombination repair, without any effect on H3 acetylation (H3ac). RSV also enhanced the SQE motif phosphorylation on T. gondii H2A.X (termed γH2A.X), a DNA damage associated PTM. Sirtinol, a specific Sir2 inhibitor also inhibited T. gondii but did not altered the acetylation status of H3 and H4K16 as well as H2A.X phosphorylation. Our findings suggest a possible link between RSV and DNA damage or DNA repair process maybe due to DNA replication stress and/or another undetermined mechanism.
- 1 August 2019
- Published by Elsevier in Experimental Parasitology
- Vol. 203, 8-18
Exploring protein myristoylation in Toxoplasma gondii
- 1 August 2019
- Published by Elsevier in Experimental Parasitology
- Vol. 203, 8-18
Exploring protein myristoylation in Toxoplasma gondii
- 1 June 2019
- Published by Elsevier in Molecular and Biochemical Parasitology
- Vol. 230, 16-23
Palmitoylation in apicomplexan parasites: from established regulatory roles to putative new functions
- 1 June 2019
- Published by Elsevier in Molecular and Biochemical Parasitology
- Vol. 230, 16-23
Palmitoylation in apicomplexan parasites: from established regulatory roles to putative new functions
- Open Access
- 24 January 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-14
Gene target discovery with network analysis in Toxoplasma gondii
Infectious diseases are of great relevance for global health, but needed drugs and vaccines have not been developed yet or are not effective in many cases. In fact, traditional scientific approaches with intense focus on individual genes or proteins have not been successful in providing new treatments. Hence, innovations in technology and computational methods provide new tools to further understand complex biological systems such as pathogen biology. In this paper, we apply a gene regulatory network approach to analyze transcriptomic data of the parasite Toxoplasma gondii. By means of an optimization procedure, the phenotypic transitions between the stages associated with the life cycle of T. gondii were embedded into the dynamics of a gene regulatory network. Thus, through this methodology we were able to reconstruct a gene regulatory network able to emulate the life cycle of the pathogen. The community network analysis has revealed that nodes of the network can be organized in seven communities which allow us to assign putative functions to 338 previously uncharacterized genes, 25 of which are predicted as new pathogenic factors. Furthermore, we identified a small gene circuit that drives a series of phenotypic transitions that characterize the life cycle of this pathogen. These new findings can contribute to the understanding of parasite pathogenesis.
- 24 January 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-14
Open AccessGene target discovery with network analysis in Toxoplasma gondii
Infectious diseases are of great relevance for global health, but needed drugs and vaccines have not been developed yet or are not effective in many cases. In fact, traditional scientific approaches with intense focus on individual genes or proteins have not been successful in providing new treatments. Hence, innovations in technology and computational methods provide new tools to further understand complex biological systems such as pathogen biology. In this paper, we apply a gene regulatory network approach to analyze transcriptomic data of the parasite Toxoplasma gondii. By means of an optimization procedure, the phenotypic transitions between the stages associated with the life cycle of T. gondii were embedded into the dynamics of a gene regulatory network. Thus, through this methodology we were able to reconstruct a gene regulatory network able to emulate the life cycle of the pathogen. The community network analysis has revealed that nodes of the network can be organized in seven communities which allow us to assign putative functions to 338 previously uncharacterized genes, 25 of which are predicted as new pathogenic factors. Furthermore, we identified a small gene circuit that drives a series of phenotypic transitions that characterize the life cycle of this pathogen. These new findings can contribute to the understanding of parasite pathogenesis.
- 1 November 2018
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 86 (11)
Brucella Hijacks Host-Mediated Palmitoylation To Stabilize and Localize PrpA to the Plasma Membrane
Brucellaceae are a group of pathogenic intracellular bacteria with the ability to modulate the host response, both at the individual cell level and systemically. One of the hallmarks of the virulence process is the capacity of the bacteria to downregulate the adaptive and acquired host immune response through a plethora of virulence factors that directly impact several key signaling cascades.
- 1 November 2018
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 86 (11)
Brucella Hijacks Host-Mediated Palmitoylation To Stabilize and Localize PrpA to the Plasma Membrane
Brucellaceae are a group of pathogenic intracellular bacteria with the ability to modulate the host response, both at the individual cell level and systemically. One of the hallmarks of the virulence process is the capacity of the bacteria to downregulate the adaptive and acquired host immune response through a plethora of virulence factors that directly impact several key signaling cascades.
- Open Access
- 1 November 2018
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 17 (11) , 2229-2241
Protein Palmitoylation Plays an Important Role in Trichomonas vaginalis Adherence
- 1 November 2018
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 17 (11) , 2229-2241
Open AccessProtein Palmitoylation Plays an Important Role in Trichomonas vaginalis Adherence
- 1 April 2016
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1864 (4) , 400-408
Identification of new palmitoylated proteins in Toxoplasma gondii
- 1 April 2016
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1864 (4) , 400-408
Identification of new palmitoylated proteins in Toxoplasma gondii